Blog
3 Growth Stocks for In-the-Know Investors
Over the past two months, rising bond yields have sparked a rotation away from pricier growth stocks and toward value stocks. Investors have also started to shun the stay-at-home stocks that
Better Buy: Veeva Systems vs. Cerner
Veeva Systems (NYSE: VEEV) and Cerner (NASDAQ: CERN) represent two different ways to invest in the digitization of the healthcare sector.
Veeva provides cloud-based customer relationship management
Meltem Demirors of CoinShares on Cryptocurrencies and Finance
It's certainly an exciting time for Bitcoin (CRYPTO: BTC) and other cryptocurrencies. In a recent Fool Live interview, recorded on March 18, Motley Fool board of directors member Randi Zuckerberg
Why This Cathie Wood Stock Is a Buy
Industrial technology company Trimble (NASDAQ: TRMB) is the largest holding in Cathie Wood's ARK Space Exploration & Innovation ETF (NYSEMKT: ARKX), and it's the second-largest holding in the ARK
Author Jim Surowiecki on Bitcoin, Cryptocurrencies, and More
Are cryptocurrencies and nonfungible tokens (NFTs) fads or bubbles? Or are they here to stay? In this Fool Live interview, recorded on March 18, The Motley Fool's chief investment officer Andy Cross
Is Norwegian Cruise Lines a Buy?
The cruise ship industry continues to take a much bigger hit than most other businesses during the COVID-19 pandemic. It remains shut down while virtually every other industry has reopened.
3 Stocks to Avoid This Week
I took a look at three stocks to avoid last week, predicting that Carnival (NYSE: CCL), BowX Acquisition (NASDAQ: BOWX), and Blink Charging (NASDAQ: BLNK) would have a bad week.
The three stocks
Why I'll Never Sell Square Stock
One of the great growth stocks over the last half-decade has been Square (NYSE: SQ), the electronic payments company. It has become a go-to payment processor for businesses large and small, and has
Better Buy: Disney vs. Netflix
Disney (NYSE: DIS) and Netflix (NASDAQ: NFLX) have emerged as the clear leaders in the streaming industry.
Netflix is the pioneer and still the biggest streaming service, with a sprawling global
The Mirror Acquisition Is Already Exceeding Lululemon's Expectations
lululemon athletica (NASDAQ: LULU) is starting to return to its pre-pandemic growth levels. Over the last three quarters, the business has steadily improved with revenue growth reaching 24% in the
How Okta Increased Its Addressable Market by $15 Billion
During its April 7 investor day, Okta (NASDAQ: OKTA) confirmed its outlook for fiscal year 2022 (ending on Jan. 31, 2022). The identity specialist also announced new developments that should vastly
Is Expedia Stock a Buy?
Expedia (NASDAQ: EXPE) stock plunged to its lowest levels since 2013 during the COVID-19 crash in March 2020 as travel restrictions cast a dark cloud over the online travel agency's future.
However
82% of Americans Say the Pandemic Hurt Their Retirement Plans. Here's How to Get Back on Track.
Though 2020 wound up being a strong year for the stock market and a lot of retirement plan balances grew during that time, many people faced setbacks on the road to planning for their senior years
3 Reasons Stay-at-Home Stocks Are Surging Again
With the accelerated rollouts of COVID-19 vaccines, you may think the stay-at-home trade is over, and the "reopening" stocks are the ones to buy today. But is that really true?
Don't look now, but
Lemonade's $800 Billion Market Opportunity -- and Why It Could Win
Insurance disruptor Lemonade (NYSE: LMND) has generated some impressive results in recent years, but the company's most exciting growth opportunity so far is yet to be reflected in the numbers. In
Can You Retire a Millionaire With Index Funds?
Can you retire as a millionaire by investing solely in index funds? I won't bury the lede: The answer to this question is undoubtedly, resoundingly, yes.
The "why" and "how" of index fund investing
Coinbase's Public Debut Is Set. Should You Invest?
Cryptocurrency exchange Coinbase is set to go public via direct listing on Wednesday, April 14. In this Fool Live video clip, recorded on April 5, Fool.com contributor Matt Frankel, CFP, and
Upstart's $1.4 Trillion Market Opportunity
Upstart Holdings (NASDAQ: UPST) has primarily been a personal lender so far, but with the recent acquisition of automotive shopping platform Prodigy Software, the company could be getting ready to
3 Bargain Stocks I Recently Bought More Of
It's certainly been an interesting market recently. The Dow Jones Industrial Average and S&P 500 index are at or near record highs, but there is a wide spectrum when it comes to sector performance
Taxes Are No Longer Due This Week -- but Here's Why You Should File Them Anyway
It's been an interesting tax-filing season, to say the least. Not only did the IRS open it up late, but the agency recently made the decision to delay the tax-filing deadline from April 15 (the
3 Robinhood Stocks With the Most Projected Downside, According to Wall Street
Over the past year, retail investors have made their presence known on Wall Street. In particular, they've flocked to popular online investing app Robinhood. We know this, because Robinhood gained
You Absolutely Shouldn't Wait Until 70 to Claim Social Security in This Situation
Most people know that Social Security checks increase if you delay claiming them.
While you become eligible for retirement benefits as early as age 62, waiting until at least your full retirement
3 Marijuana Stocks Better Than Sundial Growers That Robinhood Investors Can't Buy
Sundial Growers (NASDAQ: SNDL) ranks as the most popular cannabis stock on Robinhood. It's even the third most widely held stock overall among investors using the trading platform.
Seven other pot
A Cannabis Pro Tells Us Her Hopes for the Medical Marijuana Industry
Over the past 12 months, shares of the Horizons Marijuana Life Sciences ETF (OTC: HMLSF) have shot up over 100%. Meanwhile, pick-and-shovel play GrowGeneration (NASDAQ: GRWG) returned 1,370% to
Pfizer's About to Cut Its Dividend: What You Need to Know
Pfizer (NYSE: PFE) hasn't delivered impressive stock gains in recent years. However, investors have at least been able to count on solid and steadily increasing dividends from the big drugmaker. For


